Funding Details
- Awarder
- Inbox
- Date Award
- September 20, 2023
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
-
$23,000,000
Company Info
- Company Description
- Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.
- Market
- Pulmonary Arterial Hypertension (PAH)
- Location
-
Sunnyvale,
California,
USA
- Coinvestors
- Junson Capital, Midas Capital, New Rhein Healthcare Investors, Plaisance Capital Management, Primavera Capital
Links